GLP-1, explained.
The metabolic science behind Semaglutide and Tirzepatide — what they do, what to expect, and who they're for. Prescribed only when a clinician determines it's appropriate.
How it works
in the body.
GLP-1 is a hormone your body already makes after eating. These medications extend its effect across three metabolic pathways.
Quiets the food noise
GLP-1 acts on appetite centers in the brain, easing cravings and the constant background thoughts about food that make dieting exhausting.
Keeps you fuller, longer
It slows how quickly your stomach empties, so you feel satisfied on smaller portions and stay full for hours after eating.
Steadies blood sugar
It prompts your body to release insulin when glucose is high, helping stabilize blood sugar and reduce the swings that drive hunger.
What we
prescribe.
Semaglutide
2.5 mg/mL
Tirzepatide
5.0 mg/mL
Two proven paths.
Your clinician recommends the right protocol for your history and goals. Here is how the two compare.
A realistic
timeline.
Metabolic response is individual. This is the arc most patients follow — not a guarantee.
The food noise quiets
Many patients notice reduced cravings and a calmer relationship with food within the first several days on their starting dose.
Measurable change begins
As your body adjusts, appetite drops further and the scale typically starts to move. Your clinician monitors your telemetry throughout.
Peak therapeutic effect
After stepping up to your maintenance dose, most patients see their most significant, sustained results paired with habit change.
Is this
right for you?
A licensed clinician makes the final call from your full intake. This is a general guide to who GLP-1 therapy tends to fit.
A good fit if you are
- Adults with a BMI of 30+, or 27+ with a weight-related condition.
- Struggling to lose weight through diet and exercise alone.
- Looking for a medically supervised, data-driven program.
- Ready to pair medication with sustainable habit change.
Not appropriate if you have
- Personal or family history of MTC or MEN 2.
- Pregnant, planning pregnancy, or breastfeeding.
- History of pancreatitis or a known allergy to GLP-1 medications.
- Under 18 years of age.
What you need to know before starting.
Warning: Thyroid C-Cell Tumors
In studies with mice and rats, GLP-1 medicines caused thyroid tumors, including thyroid cancer. It is not known if these medicines will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not use if you or any of your family have ever had MTC or an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
4-minute clinical intake
Complete your comprehensive metabolic profile securely online.
US-licensed provider review
A board-certified clinician reviews your data and prescribes treatment only if it's appropriate for you.
Cold-chain shipping
Medication and hardware delivered to your door in 5–7 days.